REQUEST A DEMO
Total
USD $0.00
Search more companies

Terapia SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Terapia SA Profile Updated: March 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Terapia SA is based in Romania, with the head office in CLUJ-NAPOCA. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on May 28, 2004. There are currently 891 (2025) people employed by Terapia SA. From the latest financial highlights, Terapia SA reported a net sales revenue increase of 8.09% in 2024. Over the same period, its total assets grew by 35.63%. The enterprise’s net profit margin increased by 1.06% in 2024.

Headquarters
Strada Fabricii Nr. 124
CLUJ-NAPOCA; Cluj;

Contact Details: Purchase the Terapia SA report to view the information.

Basic Information
Total Employees:
Purchase the Terapia SA report to view the information.
Registered Capital:
Purchase the Terapia SA report to view the information.
Financial Auditors:
Purchase the Terapia SA report to view the information.
Incorporation Date:
May 28, 2004
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
96.81%
Purchase this report to view the information.
3.19%
Subsidiaries
Pharmaplant Biogalenica SRL
99.972%
Promedic SRL
99.66%
Terapia SA
95.35%
Company Performance
Financial values in the chart are available after Terapia SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
8.09%
Total Operating Revenue
7.84%
Operating Profit
11.15%
EBITDA
3.56%
Net Profit/Loss for the Period
12.9%
Total Assets
35.63%
Total Equity
23.38%
Operating Profit Margin
0.77%
Net Profit Margin
1.06%
Return on Equity (ROE)
-2.68%
Quick Ratio
-1.54%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?